Article Sidebar

Submitted
12 October 2022
Accepted
27 February 2023
Published
5 March 2023
Download
pdf
Statistic
Read Counter : 260 Download : 114

Main Article Content

Abstract

Highlights:



  1. A patient with grade IV osteoarthritis underwent an arthroplasty and developed a surgical site infection caused by Staphylococcus aureus.

  2. The treatment for the surgical site infection included antibiotic medications and revision surgery for the previous total knee arthroplasty.


Abstract:


This article presents a case report of a knee arthroplasty surgical site infection caused by non-hemolytic Staphylococcus aureus. A 56-year-old woman came to the Orthopedic Outpatient Clinic, with the chief complaint of pain in the left knee for the last three years. After being diagnosed with grade IV osteoarthritis, the patient underwent a total knee arthroplasty. The patient had routine post-operative follow-ups at the Orthopedic Outpatient Clinic. However, the patient complained of swelling, pain, and discharge at the surgical site after three months. The patient underwent a second surgery for debridement, implant removal, and interspacer placement. A broad-spectrum antibiotic (gentamicin) was administered while waiting for the culture and antibiotic sensitivity test results. The culture results showed non-hemolytic Staphylococcus aureus presence. The antibiotics were then changed and administered for two weeks according to the culture and antibiotic sensitivity test results. As the results were good, the patient was scheduled for revision surgery for her previous total knee arthroplasty.

Keywords

Surgical site infection non-hemolytic Staphylococcus aureus total knee arthroplasty human and health

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite
Satiyo, & Rosa, E. M. (2023). Surgical Site Infection caused by Non-Hemolytic Staphylococcus aureus Following a Total Knee Arthroplasty at a Class C Hospital in Indonesia. Folia Medica Indonesiana, 59(1), 57–62. https://doi.org/10.20473/fmi.v59i1.39745
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. shraf I, Mohib Y, Hasan O, et al (2018). Surgical site infection surveillance following total knee arthroplasty: Tertiary care hospital experience. Annals of Medical and Surgery 31, 14–16. doi: 10.1016/j.amsu.2018.04.006.
  2. Baier C, Adelmund S, Schwab F, et al (2019). Incidence and risk factors of surgical site infection after total knee arthroplasty: Results of a retrospective cohort study. American Journal of Infection Control 47, 1270–1272. doi: 10.1016/j.ajic.2019.04.010.
  3. Bernard L, Arvieux C, Brunschweiler B, et al (2021). Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. New England Journal of Medicine 384, 1991–2001. doi: 10.1056/NEJMoa2020198.
  4. Chaussade H, Uçkay I, Vuagnat A, et al (2017). Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks. International Journal of Infectious Diseases 63, 37–42. doi: 10.1016/j.ijid.2017.08.002.
  5. Chung H-K, Wen S-H, Chang W-C, et al (2021). Acute surgical site infection after total knee arthroplasty in patients with rheumatoid arthritis versus osteoarthritis. Scientific Reports 11, 22704. doi: 10.1038/s41598-021-02153-x.
  6. Cooper HJ, Valle CJ Della (2014). Diagnosis of periprosthetic joint infection: An algorithmic approach to patients. In Periprosthetic Joint Infection of the Hip and Knee, pp. 65–77. Springer New York, New York, NY. 4_5. doi: 10.1007/978-1-4614-7928- 4_5.
  7. Gan AK, Rahman S, Indra Nur Alam A, et al (2023). Profile of patients’ osteoarthritis at tertiary and teaching in Aceh, Indonesia. Surabaya Physical Medicine and Rehabilitation Journal J 5, 25–31. doi: 10.20473/spmrj.v5i1.36881.
  8. Gehrke T, Alijanipour P, Parvizi J (2015). The management of an infected total knee arthroplasty. The Bone & Joint Journal 97-B, 20–9. doi: 10.1302/0301-620X.97B10.36475.
  9. Goswami K, Parvizi J, Maxwell Courtney P (2018). Current recommendations for the diagnosis of acute and chronic PJI for hip and knee—Cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing. Current Reviews in Musculoskeletal Medicine 11, 428–438. doi: 10.1007/s12178-018-9513-0.
  10. Hadi N, Ishardyanto H (2021). The use of oral antibiotics to prevent surgical site infection on postoperative modified radical mastectomy patients in Dr. Soetomo General Hospital, Surabaya. Folia Medica Indonesiana 56, 36. doi: 10.20473/fmi.v56i1.24585.
  11. Karachalios T, Komnos GA (2021). Management strategies for prosthetic joint infection: Long-term infection control rates, overall survival rates, functional and quality of life outcomes. EFORT Open Reviews 6, 727–734. doi: 10.1302/2058-5241.6.210008.
  12. Karachalios T, Koutalos A, Komnos G (2014). Management strategies for infected total hip arthroplasty. A critical appreciation of problems and techniques. HIP International 24, 44–7. doi: 10.5301/hipint.5000166.
  13. Li T, Zhang H, Chan PK, et al (2022). Risk factors associated with surgical site infections following joint replacement surgery: A narrative review. Arthroplasty 4, 11. doi: 10.1186/s42836-022-00113- y.
  14. Lin F-H, Chen H-C, Lin C, et al (2018). The increase in total knee replacement surgery in Taiwan. Medicine (Baltimore) 97, e11749. doi: 10.1097/MD.0000000000011749.
  15. Mühlhofer H, Renz N, Zahar A, et al (2021). Diagnostik der periprothetischen Infektion. Deer Orthopade 50, 312–25. doi: 10.1007/s00132-020-03940-6.
  16. Osmon DR, Berbari EF, Berendt AR, et al (2013). Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the infectious diseases Society of America. Clinical Infectious Diseases 56, e1–25. doi: 10.1093/cid/cis803.
  17. Purba AKR, Luz CF, Wulandari RR, et al (2020). The impacts of deep surgical site infections on readmissions, length of stay, and costs: A matched case–control study conducted in an Academic Hospital in the Netherlands. Infection and Drug Resistance 13, 3365–74. doi: 10.2147/IDR.S264068.
  18. Purba AKR, Setiawan D, Bathoorn E, et al (2018). Prevention of surgical site infections: A systematic review of cost analyses in the use of prophylactic antibiotics. Front in Pharmacology. doi: 10.3389/fphar.2018.00776.
  19. Resende VAC, Neto AC, Nunes C, et al (2021). Higher age, female gender, osteoarthritis and blood transfusion protect against periprosthetic joint infection in total hip or knee arthroplasties: A systematic review and meta-analysis. Knee Surgery, Sports Traumatology, Arthroscopy 29, 8–43. doi: 10.1007/s00167-018-5231-9.
  20. Rosita PE, Kurniawati PM, Utomo DN (2021). Profile of age, gender, and body mass index in patient with knee osteoarthritis in Surabaya. Surabaya Physical Medicine and Rehabilitation Journal 3, 23. doi: 10.20473/spmrj.v3i1.22355.
  21. Saffanah NI, Agustina D, Sutejo IR (2020). Postoperative orthopedic surgical site infection antibiogram of dr. Soebandi Hospital, Jember in 2019. JPSCR Journal of Pharmaceutical Science and Clinical Research 5, 110. doi: 10.20961/jpscr.v5i2.41947.
  22. Shahi A, Parvizi J (2015). Prevention of periprosthetic joint infection. The Archives of Bone and Jointt Surgery 3, 72–81.
  23. Skråmm I, Fossum Moen AE, Årøen A, et al (2014). Surgical site infections in orthopaedic surgery demonstrate clones similar to those in orthopaedic staphylococcus aureus nasal carriers. Journal of Boneand Joint Surgery 96, 882–8. doi: 10.2106/JBJS.M.00919.
  24. Springer BD, Scuderi GR (2013). Evaluation and management of the infected total knee arthroplasty. Instructional Course Lectures 62, 349-61.
  25. Tande AJ, Patel R (2014). Prosthetic joint infection. Clinical Microbiology Reviews 27, 302–45. doi: 10.1128/CMR.00111-13.
  26. Weiser MC, Moucha CS (2015). The current state of screening and decolonization for the prevention of staphylococcus aureus surgical site infection after total hip and knee Arthroplasty. The Journal of Bone and Joint Surgery-American 97, 1449–1458. doi: 10.2106/JBJS.N.01114.
  27. Wenk M, Van Aken H, Zarbock A (2017). The new world health organization recommendations on perioperative administration of oxygen to prevent surgical site infections. Anesthesia & Analgesia 125, 682–687. doi: 10.1213/ ANE. 0000000000002256.
  28. World Health Organization (2019). Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level: Interim practical manual supporting implementation of the Guidelines for the prevention and control of carbapenem-res. WHO.
  29. Zahar A, Sarungi M (2021). Diagnosis and management of the infected total knee replacement: Apractical surgical guide. Journal of Experimental Orthopedics 8, 14. doi: 10.1186/s40634-021-00333-2.
  30. Zmistowski B (2014). Diagnosis of periprosthetic joint infection. Journal of Orthopaedic Research 32, S98– 107. doi: 10.1002/jor.22553.